169 related articles for article (PubMed ID: 31586511)
1. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
Kim WH; Yoon HK; Jeong CW
Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
[No Abstract] [Full Text] [Related]
2. Reply to Won Ho Kim, Hyun-Kyu Yoon, Chang Wook Jeong's Letter to Editor re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury, Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
Bravi CA
Eur Urol; 2020 Jan; 77(1):e16-e17. PubMed ID: 31590938
[No Abstract] [Full Text] [Related]
3. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Takahashi T
Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
[No Abstract] [Full Text] [Related]
4. Re: Editorial Comment from Dr Bertolo et al. to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a.
Mühlbauer J; Kowalewski KF; Kriegmair MC
Int J Urol; 2021 Jan; 28(1):133. PubMed ID: 33135222
[No Abstract] [Full Text] [Related]
5. Re: Maxine Sun, Quoc-dien Trinh, Marco Bianchi, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 2012;61:725-31.
Sandhu GS; Tanagho YS; Bhayani SB
Eur Urol; 2012 Sep; 62(3):e58; author reply e59-60. PubMed ID: 22704368
[No Abstract] [Full Text] [Related]
6. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Mouracade P
Eur Urol; 2015 Oct; 68(4):e82-3. PubMed ID: 26033152
[No Abstract] [Full Text] [Related]
7. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Potretzke AM; Larson JA; Bhayani SB
Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
[No Abstract] [Full Text] [Related]
8. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Zargar H; Coelho RF; Kaouk JH
Eur Urol; 2015 Feb; 67(2):e23. PubMed ID: 25266972
[No Abstract] [Full Text] [Related]
9. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Sep; 76(3):e67-e68. PubMed ID: 31167750
[No Abstract] [Full Text] [Related]
10. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54.
Shin TY; Abdel Raheem A; Rha KH
Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331
[No Abstract] [Full Text] [Related]
11. Editorial Comment from Dr Bertolo et al. to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a.
Bertolo R; Cipriani C; Ferro M; Bove P
Int J Urol; 2020 Oct; 27(10):914. PubMed ID: 32783281
[No Abstract] [Full Text] [Related]
12. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
[No Abstract] [Full Text] [Related]
13. Re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped "Minimal-margin" Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12.
Zu X; Qi L; Liu L
Eur Urol; 2016 Apr; 69(4):e72-e73. PubMed ID: 26489477
[No Abstract] [Full Text] [Related]
14. Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
Simpson BS; Carmona Echeverria LM; Norris JM; Ahmed HU; Moore CM; Whitaker HC
Eur Urol; 2020 Sep; 78(3):e106-e107. PubMed ID: 32527691
[No Abstract] [Full Text] [Related]
15. Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244-51.
Pecoraro A; Porpiglia F; Karakiewicz PI
Eur Urol; 2020 Mar; 77(3):e74. PubMed ID: 31607394
[No Abstract] [Full Text] [Related]
16. Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30.
Brookman-May S; Burger M; Wieland WF; May M
Eur Urol; 2011 Nov; 60(5):e45-6; author reply e47. PubMed ID: 21820239
[No Abstract] [Full Text] [Related]
17. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
[No Abstract] [Full Text] [Related]
18. Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.
Du J; Liu Y; Yan W
Eur Urol; 2020 Aug; 78(2):e64. PubMed ID: 32362499
[No Abstract] [Full Text] [Related]
19. Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):e24-5. PubMed ID: 25257032
[No Abstract] [Full Text] [Related]
20. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
